By S.J. Enna and Michael Williams (Eds.)
Every one quantity of Advances in Pharmacology offers a wealthy selection of reports on well timed subject matters. Emphasis is put on the molecular foundation of drug motion, either utilized and experimental.Articles written by means of prime investigators within the fieldInforms and updates on all of the most recent advancements
Read or Download Contemporary Aspects of Biomedical Research: Drug Discovery PDF
Best nonfiction_3 books
This booklet compares for the 1st time how the areas in seven diversified international locations (Austria, Belgium, France, Germany, Italy, Spain and the united kingdom) are fascinated by european governance. it's also the 1st publication which tackles this topic from various views; that of ecu legislations and that of comparative legislations.
This powerfully iconoclastic ebook reconsiders the influential nativist place towards the brain. Nativists assert that a few ideas, ideals, or capacities are innate or inborn: "native" to the brain instead of got. Fiona Cowie argues that this view is flawed, demonstrating that nativism is an risky amalgam of 2 particularly different--and most likely inconsistent--theses concerning the brain.
Helping first-time headteachers make the transition to formal management, this source offers crucial aid and encouragement to aid them satisfy their capability as academic leaders.
- Language and Conflict: A Neglected Relationship
- A Protocol for Touch (Vassar Miller Prize in Poetry, 7)
- Going to Court. Information and advice for Crown Court witnesses aged 17 and under (The Young Witness Pack)
- Essentials of Ramadan: The fasting month
Extra resources for Contemporary Aspects of Biomedical Research: Drug Discovery
Pharmacological Reviews, 48, 413–463. Kenakin, T. (2009). A pharmacology primer. ). Burlington, MA: Elsevier Academic Press. , et al. (2004). Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. British Journal of Pharmacology, 142, 1059–1072. , Parchment, R. , Murgo, A. , et al. (2007). Phase 0 clinical trials in cancer drug development: From FDA guidance to clinical practice. Molecular Interventions, 7, 325–334. Kirsch, I. (2009). The emperor’s new drugs: Exploding the antidepressant myth.
Gaynes, B. , Luther, J. , et al. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STARÃD report. American Journal of Psychiatry, 166, 599–607. Williams, M. (2004). A return to the fundamentals of drug discovery? Current Opinion in Investigational Drugs, 5, 1–3. Williams, M. (2005). Systems and integrative biology as alternative guises for pharmacology: Prime time for an iPharm concept? Biochemical Pharmacology, 70, 1707–1716. Williams, M.
2009). The emperor’s new drugs: Exploding the antidepressant myth. London: The Bodley Head. , Deacon, B. , Huedo-Medina, T. , Moore, T. , & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, e45. , Moore, T. , & Nicholls, S. S. (2002). The emperor’s new drugs: An analysis of antidepressant medication data submitted to the U. S. Food and Drug Administration. Prevention & Treatment, article 23.